Establishing Continuous Reference Intervals for Alkaline Phosphatase in the Pediatric Population from 2 Tertiary

Hatice Saracoglu1, Gozde Erturk Zararsiz2, Fatma Demet Arslan3

  • 1Department of Medical Biochemistry, Erciyes University Faculty of Medicine, Kayseri, Türkiye.

Insights

New age- and sex-specific continuous alkaline phosphatase (ALP) reference intervals (RIs) were established for children. Regional differences in pediatric ALP levels were also identified, highlighting the need for localized RIs.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Clinical Chemistry

Background:

  • Alkaline phosphatase (ALP) levels in children exhibit significant age and sex variability.
  • Establishing accurate reference intervals (RIs) is crucial for interpreting pediatric ALP test results.
  • Previous RIs may not fully capture the dynamic changes in ALP during childhood and adolescence.

Purpose of the Study:

  • To determine age- and sex-specific continuous reference intervals (RIs) for alkaline phosphatase (ALP) in the pediatric population.
  • To compare local RIs for pediatric ALP between two distinct regions in Türkiye (Kayseri and Izmir).
  • To evaluate the utility of continuous RIs for improved interpretation of pediatric ALP levels.

Main Methods:

  • Retrospective analysis of ALP activity in pediatric patients (0-18 years) from two tertiary centers in Türkiye.
  • Development of continuous RIs using the Generalized Additive Models for Location, Scale, and Shape (GAMLSS) method.
  • Calculation of discrete RIs following the Clinical and Laboratory Standards Institute EP28-A3c guideline.

Main Results:

  • Sex-specific continuous RIs demonstrated distinct ALP patterns throughout childhood and adolescence.
  • Females showed an ALP peak around age 11, while males peaked around age 13.
  • Higher ALP levels were observed in Kayseri compared to Izmir, with significant regional differences emerging in later adolescence.

Conclusions:

  • Continuous RIs offer a more precise and adaptable method for interpreting pediatric ALP results, accounting for age and sex variations.
  • The study emphasizes the clinical significance of region- and sex-specific RIs for accurate pediatric ALP evaluation.
  • Implementing these localized RIs can enhance diagnostic accuracy and clinical decision-making in pediatric care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...